Selv om det ikke er undersøgt, anbefales det, at patienterne ikke får levende virale vacciner i mindst 12 måneder efter behandling med MabCampath.
Although it has not been studied, it is recommended that patients should not receive live viral vaccines in, at least, the 12 months following MabCampath therapy.